Distinguished Professor, Departments of Psychiatry and Family & Preventive Medicine
Murray B. Stein, M.D., MPH, FRCPC
Murray B. Stein, M.D., MPH, FRCPC
Vice Chair for Clinical Research in Psychiatry
Adjunct Professor, San Diego State University (SDSU) Department of Psychology
Adjunct Professor, University of Manitoba Department of Psychiatry
Director, UCSD Anxiety & Traumatic Stress Disorders Research Program
Director, Injury and Traumatic Stress (INTRuST) Clinical Consortium
Scientific Council Member (Joined 2014)
Murray B Stein MD, MPH, FRCPC is Distinguished Professor of Psychiatry and Family & Preventive Medicine and Vice Chair for Clinical Research in Psychiatry at the University of California San Diego (UCSD), where he directs the Anxiety & Traumatic Stress Disorders Program. He is also a Staff Psychiatrist at the VA San Diego Healthcare System. Dr. Stein graduated from the University of Manitoba and completed his residency and post-residency fellowship at the University of Toronto and at the National Institute of Mental Health in Bethesda, Maryland, USA. He subsequently completed a Master of Public Health degree at the Johns Hopkins University Bloomberg School of Public Health in Baltimore, Maryland.
Dr. Stein’s research interests include the epidemiology, neurobiology, and treatment of anxiety disorders especially social phobia, panic disorder, and posttraumatic stress disorder. He has written or co-written over 500 peer-reviewed scientific articles on these topics, including in journals such as Journal of the American Medical Association, The Lancet, American Journal of Psychiatry, and JAMA Psychiatry. He is co-editor, with Martin Antony PhD, of the Oxford Handbook of Anxiety and Related Disorders (2009). His federally funded research has included studies of interventions for anxiety disorders in primary care, pharmacological approaches to treatment-resistant anxiety disorders, and functional neuroimaging research in anxiety and trauma-related disorders. He is Principal Investigator and Director of the Department of Defensefunded (2008-2014) INjury and TRaumatic STress (INTRuST) Consortium, which studies treatments for Posttraumatic Stress Disorder and Traumatic Brain Injury. He is also Co-Principal Investigator (with Robert Ursano MD) of Army STARRS, an NIMH-funded project (2009-2014) investigating risk factors for suicide and other deployment-related disorders.
Dr. Stein is a member of the Board of Directors of the Anxiety and Depression Association of America (ADAA), a Fellow of the American College of Neuropsychopharmacology (ACNP), Co-Editor-in-Chief for UpToDate in Psychiatry, and Deputy Editor for the journal Biological Psychiatry. Dr. Stein chaired the American Psychiatric Association Workgroup to Revise the Panic Disorder Treatment Guidelines (2006-2008), and is past Scientific Chair of the NIMH Interventions in Mood and Anxiety (ITMA) Review Group (2006-2009). Dr. Stein was a member of the DSM-5 Anxiety, Obsessive-Compulsive Spectrum, Posttraumatic, and Dissociative Disorders Work Group (2009-2013). He is currently a member of the Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) (2011- 2016) and a member of the Institute of Medicine (IOM) Board on the Health of Select Populations (2012-2015)
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.